Nexalin Technology (NXL) Non-Current Assets (2021 - 2026)
Nexalin Technology (NXL) recorded quarterly Non-Current Assets of $404479.0 in Q1 2026, up 20.36% quarter-over-quarter from $336049.0 in Q4 2025, and up 44.7% on a YoY basis from $279520.0 in Q1 2025.
Nexalin Technology (NXL) Non-Current Assets (2021 - 2026) Analysis & Trends
Nexalin Technology's Non-Current Assets history runs 6 years deep, the most recent figure standing at $404479.0 for Q1 2026.
- In Q1 2026, Non-Current Assets rose 44.7% year-over-year to $404479.0; the TTM figure through Mar 2026 stood at $1.3 million (up 5.68% YoY), while the FY2025 annual figure was $336049.0, up 28.46% from the prior year.
- Non-Current Assets was $404479.0 for Q1 2026 at Nexalin Technology, up from $336049.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $404479.0 in Q1 2026 to a low of $6674.0 in Q4 2022.
- Historically, Non-Current Assets has averaged $226154.0 across 5 years, with a median of $270957.0 in 2024.
- The sharpest annual moves came in 2023 and 2025: Non-Current Assets jumped 2927.03% in 2023, then declined 22.6% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $6674.0 in 2022, then surged by 2927.03% to $202024.0 in 2023, then grew by 29.49% to $261591.0 in 2024, then gained by 28.46% to $336049.0 in 2025, then gained by 20.36% to $404479.0 in 2026.
- The last three Non-Current Assets figures came in at $404479.0 (Q1 2026), $336049.0 (Q4 2025), and $308562.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 67.41 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.47 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.30 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 8.34 Bn |
| 10 | Nexalin Technology | 7.82 Mn | 5.11 Mn | 13,133.00 | 404,479.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 404,479.00 |
| Dec 31, 2025 | 336,049.00 |
| Sep 30, 2025 | 308,562.00 |
| Jun 30, 2025 | 294,871.00 |
| Mar 31, 2025 | 279,520.00 |
| Dec 31, 2024 | 261,591.00 |
| Sep 30, 2024 | 349,593.00 |
| Jun 30, 2024 | 380,983.00 |
| Mar 31, 2024 | 270,957.00 |
| Dec 31, 2023 | 202,024.00 |
| Sep 30, 2023 | 170,418.00 |
| Jun 30, 2023 | 63,737.00 |
| Mar 31, 2023 | 54,704.00 |
| Dec 31, 2022 | 6,674.00 |
| Sep 30, 2022 | 8,148.00 |
| Dec 31, 2021 | 1,039.00 |